Submission of Summary Bioequivalence data for ANDAs

Submission of Summary Bioequivalence Data for ANDAs

read all at

http://www.fda.gov/downloads/Drugs/…/Guidances/UCM134846.pdf

1. http://www.fda.gov/downloads/Drugs/…/Guidances/UCM134846.pdf‎

   Guidance for Industry. Submission of Summary. Bioequivalence Data for ANDAs. U.S. Department of Health and Human Services. Food and Drug Administration.

2. Bioequivalence Studies Rule Specific Products Guidance Process

   http://www.fda.gov/…/HowDrugsareDevelopedandApproved/…/AbbreviatedN…‎

   Division of Bioequivalence 2, Office of Generic Drugs. Center for … Requires ANDA applicants to submit data … Should submit a complete or summary report for.

3. 
   

   Guidance for Industry – Food and Drug Administration

   http://www.fda.gov/OHRMS/DOCKETS/98fr/FDA-2009-D-0126-gdl.pdf‎

   Guidance for Industry. Submission of Summary. Bioequivalence Data for ANDAs. Additional copies are available from: Office of Communication. Division of Drug  …

4. Abbreviated New Drug Application (ANDA): Generics > Generic …

   http://www.fda.gov/…/HowDrugsareDevelopedandApproved/…/AbbreviatedN…‎

   6 days ago – “Original Abbreviated New Drug Approvals (ANDAs) by Month” for Generic … Model Bioequivalence Data Summary Tables (PDF – 219KB) The  …

   view presentation

   

ANDA Bioequivalence Studies That Fail to Meet FDA’s Current

var docstoc_docid=”52321985″;var docstoc_title=”ANDA Bioequivalence Studies That Fail to Meet FDA’s Current”;var docstoc_urltitle=”ANDA Bioequivalence Studies That Fail to Meet FDA’s Current”;
http://www.docstoc.com/docs/document-preview.aspx?doc_id=52321985

Advertisement